The susceptibility to alpha/beta interferon 
Successful resolution of a viral infection depends upon a critical balance between the extent of viral spread and replication and the magnitude of the host's immune response. Class I-restricted antiviral cytotoxic T cells (CTL), antiviral cytokines, and antibodies are involved in the recovery of a host from many acute viral infections (for reviews, see references 9 and 21). Disturbance of this balance may lead to persistence of infectious virus in the host. This may be the result of different mechanisms such as modulation of viral or major transplantation antigens, escape from T-or B-cell response, hiding in privileged sites, or immune suppression; also, the rapid growth, distribution, and wide cell tropism of viruses in vivo seem to contribute crucially to persistence of non-or poorly cytopathic viruses in an immunocompetent host (for reviews, see references 3, 21, and 23).
Lymphocytic choriomeningitis virus (LCMV) is a noncytopathic RNA virus for which mice are the natural host and reservoir (I 1, 16, 24) . Several LCMV strains have been isolated from human patients or from LCMV carrier mice (1, 8, 16, 26) . These isolates vary widely (and according to the host genetics) with respect to their capacity to induce immunity, T-cellmediated immunopathology, and/or persistence in immunocompetent mice (1, 11, 26) . For example, infection of C57BL/6 mice with high doses of 106 or 1(7 PFU of LCMV WE, Aggressive, or Armstrong induces a CD8+ antiviral CTL response which results in clearance of virus from the animals within 2 weeks. After infection with the same dose of LCMV Traub, virus is cleared only after 2 to 4 months; infection with LCMV Docile or LCMV Cl 13-Armstrong usually induces a long-lasting or even lifelong virus persistence. A remarkable property of the last two isolates is their ability to The quantification of infectious virus in mouse tissues has been described in detail previously (17) 24 -well plates and incubated for 20 h at 37°C in minimal essential medium or IMDM containing 5% fetal calf serum and various concentrations of murine recombinant IFN--y (Ernst Boehringer Institut fur Arzneimittelforschung) (10,000, 100, or 10 U/ml) or purified mouse IFN-ot/ (Lee Biomolecular Research Inc., San Diego, Calif.) (1,000, 100, or 10 U/ml). The cell monolayers were infected with various strains of LCMV at a multiplicity of infection (MOI) of 0.1 to 0.0001. After 1 h of adsorption of virus at 37°C, the inoculum was removed and the cells were washed twice to remove nonadherent virus. Finally, 1.5 ml of fresh minimal essential medium (L929 cells) or IMDM (RAW265 cells) containing 5% fetal calf serum and the same concentration of IFN-&/13 or recombinant IFN-y was added.
Supernatants were harvested from individual wells at various time intervals and titrated as described above.
RESULTS
Role of endogenous IFN-'y in the replication of LCMV strains in the spleens of C57BL/6 mice. To assess the influence of endogenous IFN--y on the replication in situ of various LCMV strains, C57BL/6 mice were infected i.v. with 100 PFU of WE, Aggressive, Docile, Armstrong, Cl 13-Armstrong, or Traub; endogenous IFN-y was neutralized by treatment of mice with sheep anti-IFN-y serum (Fig. la to f and Table 1 ). Treatment with anti-IFN--y enhanced virus replication in comparison with control antibodies in mice infected with LCMV WE (P < 0.001 on days 1, 2, 3, and 4 and P < 0.002 on day 1.5), Aggressive (P < 0.001 on days 1.5 and 3 and P < 0.002 on day Endogenous IFN-ot and -Il influence the replication of LCMV strains in distinct patterns. To evaluate the role of IFN-ax and -3 on replication of various LCMV strains, C57BL/6 mice were treated with anti-IFN-af/3 or control serum 4 h before and 36 and 72 h after infection with 100 PFU of LCMV i.v.; virus titers were determined in the spleen (Fig.   2 ). Neutralization of IFN-oo/p enhanced the replication of all LCMV isolates. However, neutralization of IFN-ox/ caused two distinct effects on virus replication. In anti-IFN-un/,-treated mice, LCMV isolate WE, Armstrong, or Aggressive exhibited an accelerated kinetics very early on day 1.5. In mice infected with LCMV Docile, Cl 13-Armstrong, or Traub, virus titers in the spleens did not differ on day 1.5; instead, anti-IFNox/, caused significantly higher titers only on day 3 and day 5 ( Fig. 2 and Table 1 Fig. 3 ; the other (Fig. 3 ) time points were also evaluated for all combinations and gave treated with antibodies against IFN--y or IFN-ox/ may reflect either resistance to these cytokines or lower levels of induced interferons by the various virus strains. To explore these possibilities, C5713L/6 mice were infected with a relatively low dose (100 PFU i.v.) of different LCMV isolates. IFN-y levels were determined in sera of LCMV-infected mice, by enzymelinked immunosorbent assay, but concentrations were all below the limit of detection (10 U/ml). In (6) . These findings may suggest a possible role of such virus variants in virus persistence associated with subacute sclerosing panencephalitis. Adenoviruses are usually relatively resistant to interferon. This resistance was recently mapped to El proteins (14) that block interferon induction of oligoadenylate synthetase mRNAs at the transcriptional level (7) . Resistance to IFN-cx/3 was also described for herpes simplex virus type 1 in comparison with a less virulent strain of herpes simplex virus type 1 (29, 30) . In addition, the factor encoded by the 1,828-bp BamHI DNA fragment of hepatitis B virus with suppressive activity for human IFN-3 genes has been implied in virus persistance of hepatitis B virus in humans (33) .
What are the mechanisms by which interferon resistance influences the ability of certain LCMV isolates to establish persistent infections in adult mice? The molecular basis for interferon resistance in certain LCMV strains and mutants is not known yet. The amino acid differences between Armstrong and Cl 13-Armstrong in the glycoprotein (amino acid 260) and changes in the L-RNA coding for the polymerase are possible candidates (2, 20, 28) . The relevant sequence information is not available yet for LCMV Aggressive and Docile, but the amino acid position 260 is the same for the LCMV isolates Cl 13-Armstrong, Aggressive, and Docile (21a) and therefore cannot alone explain the differences.
Although probably the virus-host relationship is more com-
